Target intelligence / Profile preview

SIN3 transcription regulator family member A (SIN3A)

Target
SIN3A
Molecular classification
Transcriptional coregulator, Transcriptional co-repressor, Chromatin remodeling protein, Scaffold protein (of SIN3/HDAC complex), Histone modification (through complex with histone deacetylases, chiefly HDAC1/2)
01

Overview

SIN3 transcription regulator family member A (SIN3A) is a large, highly conserved transcriptional co-regulator that acts as the central scaffold subunit of the multi-protein SIN3/HDAC histone deacetylase complex. It contains several paired amphipathic helix (PAH) domains and interacts with diverse chromatin-modifying enzymes, including HDAC1/2, and multiple transcription factors such as REST and MXD1-MAX heterodimers for gene repression. SIN3A complexes modulate gene expression by remodeling chromatin through histone deacetylation, and their genome-wide occupancy is found at many active promoters. The protein displays dual activity, functioning as both a transcriptional repressor and an activator depending on complex context and interacting partners. SIN3A is essential for vital biological processes, including regulation of the cell cycle, pluripotency, neuronal differentiation, circadian rhythms, and the transcriptional response to hypoxia. Germline mutations or deletions in SIN3A cause neurodevelopmental disorders like Witteveen-Kolk syndrome and are associated with chromosome 15q24 deletion syndrome. SIN3A-containing complexes are implicated in cancer, particularly through their regulation of MYC and cell cycle genes. While currently not a direct drug target, the essential role of SIN3A in chromatin regulation makes it a critical node in gene regulatory networks with both therapeutic promise and toxicity risk if modulated

Other names
Paired amphipathic helix protein Sin3aKIAA0700DKFZP434K2235Histone deacetylase complex subunit Sin3aTranscriptional corepressor Sin3aCHR15DELq24DEL15Q24WITKOSSIN3 homolog Atranscriptional co-repressor Sin3Atranscriptional coregulator Sin3a
02

Mechanism of action

Indirect mechanisms only—HDAC inhibitors disrupt the SIN3A-containing complexes by inhibiting their core enzymatic (HDAC1/2) activity, affecting gene repression

03

Biological functions

Regulation of gene expression/transcription (repression and activation)Chromatin remodelingCell cycle regulationPluripotency and stem cell maintenanceDifferentiation (e.g., neuronal, cortical neuron differentiation)ApoptosisCell proliferationRegulation of circadian rhythmsResponse to hypoxia
04

Disease associations

CancerNeurodevelopmental disorder (Witteveen-Kolk syndrome)Chromosome 15q24 deletion syndromePotential roles in other developmental and genetic disorders
05

Safety considerations

Broad transcriptional effects and essential role in pluripotency, cell cycle, and development imply that direct inhibition, loss, or modulation could cause widespread toxicities, including developmental abnormalities, impaired cell differentiation, and possible carcinogenesis
06

Interacting drugs

None established as direct modulators currently. HDAC1/2 inhibitors (e.g., vorinostat, romidepsin) may indirectly affect complexes containing SIN3A, but there are no known selective SIN3A-targeting drugs
07

Biomarkers

No direct established biomarkers for patient selection or efficacy monitoring involving SIN3A, but genetic loss of function (e.g., deletion, mutation) defines Witteveen-Kolk syndrome and 15q24 deletion syndromes

Beyond the preview

Go deeper on SIN3 transcription regulator family member A (SIN3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SIN3 transcription regulator family member A (SIN3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call